- Home
- NUWE vs POAI Comparison
NUWE vs POAI Comparison
Compare NUWE & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- POAI
- Stock Information
- Founded
- NUWE 1999
- POAI 2002
- Country
- NUWE United States
- POAI United States
- Employees
- NUWE N/A
- POAI N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- POAI Industrial Specialties
- Sector
- NUWE Health Care
- POAI Health Care
- Exchange
- NUWE Nasdaq
- POAI Nasdaq
- Market Cap
- NUWE 5.1M
- POAI 4.9M
- IPO Year
- NUWE N/A
- POAI N/A
- Fundamental
- Price
- NUWE $1.21
- POAI $1.21
- Analyst Decision
- NUWE Strong Buy
- POAI Hold
- Analyst Count
- NUWE 1
- POAI 1
- Target Price
- NUWE $17.00
- POAI N/A
- AVG Volume (30 Days)
- NUWE 316.1K
- POAI 3.4M
- Earning Date
- NUWE 03-04-2025
- POAI 11-12-2024
- Dividend Yield
- NUWE N/A
- POAI N/A
- EPS Growth
- NUWE N/A
- POAI N/A
- EPS
- NUWE N/A
- POAI N/A
- Revenue
- NUWE $8,969,000.00
- POAI $1,484,223.00
- Revenue This Year
- NUWE $2.18
- POAI N/A
- Revenue Next Year
- NUWE $25.75
- POAI $569.48
- P/E Ratio
- NUWE N/A
- POAI N/A
- Revenue Growth
- NUWE 3.66
- POAI N/A
- 52 Week Low
- NUWE $0.92
- POAI $0.55
- 52 Week High
- NUWE $27.65
- POAI $3.76
- Technical
- Relative Strength Index (RSI)
- NUWE 53.66
- POAI 54.24
- Support Level
- NUWE $0.99
- POAI $1.16
- Resistance Level
- NUWE $1.26
- POAI $1.42
- Average True Range (ATR)
- NUWE 0.08
- POAI 0.36
- MACD
- NUWE 0.02
- POAI -0.00
- Stochastic Oscillator
- NUWE 81.48
- POAI 19.21
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.